Expert Opinion on Therapeutic Targets This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Airway smooth muscle in contractility and remodeling of asthma: potential drug target mechanisms
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 14, 2023 Category: Drugs & Pharmacology Authors: Latifa Khalfaoui Christina M. Pabelick Source Type: research

Type 1 diabetes: key drug targets and how they could influence future therapeutics
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 13, 2023 Category: Drugs & Pharmacology Authors: Yoon Kook Kim Kashif M. Munir Stephen N. Davis Source Type: research

H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 12, 2023 Category: Drugs & Pharmacology Authors: Julian S. Rechberger Blake T. Power Erica A. Power Cody L. Nesvick David J. Daniels Source Type: research

The sweet side of wound healing: galectins as promising therapeutic targets in hemostasis, inflammation, proliferation, and maturation/remodeling
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 9, 2023 Category: Drugs & Pharmacology Authors: Mat úš Čoma Joachim C Manning Herbert Kaltner Peter G ál Source Type: research

Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 7, 2023 Category: Drugs & Pharmacology Authors: Zonghui Ma Andrew A. Bolinger Jia Zhou Bing Tian Source Type: research

Targeting endoplasmic reticulum stress —the responder to lipotoxicity and modulator of non-alcoholic fatty liver diseases
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 31, 2023 Category: Drugs & Pharmacology Authors: Yu Luo Qiangqiang Jiao Yuping Chen Source Type: research

The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 29, 2023 Category: Drugs & Pharmacology Authors: Natsuki Furukawa Vered Stearns Cesar A. Santa-Maria Aleksander S. Popel Source Type: research

The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 24, 2023 Category: Drugs & Pharmacology Authors: Mohammad Sadeghi Atefeh Khodakarami Armin Ahmadi Mehrdad Fathi Jamshid Gholizadeh Navashenaq Hamed Mohammadi Mehdi Yousefi Mohammad Hojjat-Farsangi Ali Akbar Movasaghpour Akbari Farhad Jadidi-Niaragh Source Type: research

Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 19, 2023 Category: Drugs & Pharmacology Authors: M. Martin VandenBroek Sofia I. Skebo Mark L Ormiston Source Type: research

Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 12, 2023 Category: Drugs & Pharmacology Authors: Chanichon Chomchoei James Michael Brimson Sirikalaya Brimson Source Type: research

Targeting protein clearance pathways in GBA1-associated Parkinson disease
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 12, 2023 Category: Drugs & Pharmacology Authors: Chase Chen Ellen Hertz Yu Chen Ellen Sidransky Source Type: research

DDX3: a relevant therapeutic target for lymphoma?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 10, 2023 Category: Drugs & Pharmacology Authors: Marion Lacroix Hugues Beauchemin Tarik M öröy Source Type: research

Beyond basic research: the contribution of cathepsin B to cancer development, diagnosis and therapy
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 2, 2023 Category: Drugs & Pharmacology Authors: Andrey A Zamyatnin Levy C Gregory Paul A Townsend Surinder M Soond Source Type: research

Kidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 28, 2022 Category: Drugs & Pharmacology Authors: Konrad Zuzda Wiktoria Grycuk Jacek Ma łyszko Jolanta Ma łyszko Source Type: research

Targeting the CTLA-4/B7 axes in glioblastoma: preclinical evidence and clinical interventions
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 28, 2022 Category: Drugs & Pharmacology Authors: Mehrdad Fathi Seyed-Mostafa Razavi Mozhdeh Sojoodi Armin Ahmadi Farbod Ebrahimi Afshin Namdar Mohammad Hojjat-Farsangi Sharareh Gholamin Farhad Jadidi-Niaragh Source Type: research